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Description
[0001] The present invention relates to an improved method for the specific production of unsaturated ω-3 fatty acids
and a method for the production of triglycerides having an increased content of unsaturated fatty acids, in particular ω-
3 fatty acids having more than three double bonds. The invention relates to the production of a transgenic organism,
preferably a transgenic plant or a transgenic microorganism, having an increased content of fatty acids, oils or lipids
having ∆6 double bonds due to the expression of a ∆ 6-desaturase from Primulaceae.
[0002] The invention additionally relates to expression cassettes containing a nucleic acid sequence, a vector and
organisms containing at least one nucleic acid sequence or an expression cassette. The invention further relates to
unsaturated fatty acids and triglycerides having an increased content of unsaturated fatty acids and use thereof.
[0003] Fatty acids and triglycerides have numerous applications in the food industry, animal nutrition, cosmetics and
in the drug sector. Depending on whether they are free saturated or unsaturated fatty acids or are triglycerides having
an increased content of saturated or unsaturated fatty acids, they are suitable for the most varied applications. Thus,
for example, polyunsaturated fatty acids are added to infant formula to increase its nutritional value. The various fatty
acids and triglycerides are mainly obtained from microorganisms such as Mortierella or from oil-producing plants such
as soybean, oilseed rape, sunflower and others, and generally occur in the form of their triacylglycerides. However, they
may also be obtained from animals, e.g. fish. The free fatty acids are advantageously produced by saponification.
[0004] Depending on application purpose oils containing saturated or unsaturated fatty acids are preferred, thus in
human nutrition for example, lipids containing unsaturated fatty acids, especially polyunsaturated fatty acids, are preferred
since they have a positive effect on the level of cholesterol in the blood and hence on the possibility of heart disease.
They are employed in various dietary foods or medicinal drugs.
[0005] On account of their positive properties there has been no shortage of attempts in the past to make available
genes which participate in the synthesis of fatty acids or triglycerides for the production of oils in various organisms
having a modified content of unsaturated fatty acids. Thus, in WO 91/13972 and its US equivalent a ∆ 9- desaturase is
described. In WO 93/11245 a ∆ 15-desatura and in WO 94/11516 a ∆ 12-desaturase is claimed. Other desaturases are
described, for example, in EP- A-0 550 162, WO 94/18337, WO 97/30582, WO 97/21340, WO 95/18222, EP- A-0 794
250, Stukey et al., J. Biol. Chem., 265, 1990: 20144-20149, Wada et al., Nature 347, 1990: 200-203 or Huang et al.,
Lipids 34, 1999: 649-659. To date, however, the various desaturases have been only inadequately characterized bio-
chemically since the enzymes in the form of membrane-bound proteins are isolable and characterizable only with very
great difficulty (McKeon et al., Methods in Enzymol. 71, 1981: 12141-12147, Wang et al., Plant Physiol. Biochem., 26,
1988: 777-792). Generally, membrane-bound desaturases are characterized by introduction into a suitable organism
which is then investigated for enzyme activity by means of analysis of starting materials and products. ∆ 6-Desaturases
are described in WO 93/06712, US 5,614,393, US 5614393, WO 96/21022, WO0021557 and WO 99/27111 and their
application to production in transgenic organisms is also described, e.g. in WO 9846763, WO 9846764 and WO 9846765.
At the same time the expression of various desaturases, as in WO 9964616 or WO 9846776, and the formation of
polyunsaturated fatty acids is also described and claimed. With regard to the effectiveness of the expression of desat-
urases and their effect on the formation of polyunsaturated fatty acids it may be noted that through expression of a single
desaturase as described to date only low contents of ∆ 6 unsaturated fatty acids/ lipids, such as by way of example
gamma- linolenic acid and stearidonic acid, have been achieved. Furthermore, a mixture of ω-3 and ω-6 fatty acids was
usually obtained since all ∆ 6- desaturases described so far converted, for example, linoleic acid (ω-6 fatty acid) as well
as α-linolenic acid (ω-3 fatty acid).
[0006] Accordingly, there is still a great demand for new and more suitable genes which encode enzymes which
participate in the biosynthesis of unsaturated fatty acids and make it possible to produce certain fatty acids specifically
on an industrial scale without unwanted byproducts forming. In the selection of genes for biosynthesis two characteristics
above all are particularly important. On the one hand, there is as ever a need for improved processes for obtaining the
highest possible contents of polyunsaturated fatty acids. On the other hand, the enzymes employed should be highly
specific to a certain substrate since as far as possible unwanted byproducts must not be produced which might have
negative or so far undiscovered physiological effects in humans or animals due to food/feed intake.
[0007] Accordingly, it is an object of the present invention to introduce further genes of desaturase enzymes for the
synthesis of polyunsaturated fatty acids into the seeds of an oil seed and in doing so to prevent the production of unwanted
byproducts. We have found that this object is achieved by the isolated nucleic acid sequences according to the invention
which encode polypeptides having ∆ 6-desaturase activity, wherein the ∆ 6-desaturases encoded by the nucleic acid
sequences specifically convert ω-3 fatty acids. This object was achieved in particular by cloning the isolated nucleic acid
sequences according to the invention, wherein the nucleic acid sequences encode a polypeptide having ∆ 6-desaturase
activity, wherein the ∆ 6- desaturases encoded by the nucleic acid sequences specifically convert ω-3 fatty acids selected
from the group: 
a) a nucleic acid sequence having the sequence depicted in SEQ ID NO: 1 or SEQ ID NO: 3,
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b) nucleic acid sequences which may be derived as a result of the degenerated genetic code from the encoding
sequence contained in SEQ ID NO: 1 or SEQ ID NO: 3,
c) derivatives of the nucleic acid sequence depicted in SEQ ID NO: 1 or SEQ ID NO: 3 which encode polypeptides
using the amino acid sequences depicted in SEQ ID NO: 2 or SEQ ID NO: 4 and have at least 75 % homology on
the amino acid level with SEQ ID NO: 2 or SEQ ID NO: 4 and possess ∆ 6- desaturase activity
[0008] The nucleic acid sequences according to the invention which encode polypeptides having a ∆ 6-desaturase
activity and originate from plants, advantageously Primulaceae such as Muscariodides or Aleuritia are specific for the
conversion of ω-3 fatty acids and thus they preferably convert by way of example α-linolenic acid and not linoleic acid
when they are expressed in a heterologous system and both fatty acids are available in the organism. By this means
e.g. stearidonic acid, eicosapentaenoic acid or docosahexaenoic acid are produced in the host organisms such as plants
or microorganisms without formation of arachidonic acid. This results in an advantageous synthesis of fatty acids of the
ω-3 fatty acid family, while ω-6 fatty acids are scarcely formed if they occur at all. The ∆ 6- desaturases according to the
invention exhibit a higher activity towards ω-3 fatty acids as compared to ω-6 fatty acids by at least the factor 1.5,
advantageously by at the least the factor 2, preferably by at least the factor 3, particularly preferably by at least the factor
4 and most particularly preferably by at least the factor 5. Due to this specificity the formation of unwanted fatty acids
can be suppressed or completely prevented.
[0009] By derivative (s) of the sequences according to the invention is meant, for example, functional homologues of
the polypeptides or enzymes encoded by SEQ ID NO: 1 or SEQ ID NO: 3 which exhibit the same said specific enzymatic
activity. This specific enzymatic activity allows advantageously the synthesis of unsaturated fatty acids having more than
three double bonds in the fatty acid molecule. By unsaturated fatty acids is meant in what follows diunsaturated or
polyunsaturated fatty acids which possess double bonds. The double bonds may be conjugated or nonconjugated. The
said sequences encode enzymes which exhibit ∆6-desaturase activity.
[0010] The enzyme according to the invention, ∆ 6-desaturase, advantageously introduces a cis double bond into
fatty acid residues of glycerolipids at position C6-C7 (see SEQ ID NO: 1 and SEQ ID NO: 3). The enzymes additionally
have a ∆6-desaturase activity which advantageously introduces exclusively a cis double bond into fatty acid residues
of glycerolipids at position C6-C7. This activity is also possessed by the enzymes having the sequences specified in
SEQ ID NO: 1 and NO: 3 which are monofunctional ∆ 6- desaturases.
[0011] The nucleic acid sequence(s) according to the invention (for purposes of the application the singular encom-
passes the plural and vice versa) or fragments thereof may advantageously be used for isolating other genomic sequences
via homology screening.
[0012] The said derivatives may be isolated, for example, from other organisms, eukaryotic organisms such as plants,
especially mosses, dinoflagellates or fungi.
[0013] Allele variants include in particular functional variants obtainable by deletion, insertion or substitution of nucle-
otides in the sequences depicted in SEQ ID NO: 1 or SEQ ID NO: 3, the enzymatic activity of the derived synthesized
proteins being retained.
[0014] Starting from the DNA sequence described in SEQ ID NO: 1 and SEQ ID NO: 3 or parts of said sequences
such DNA sequences can be isolated using, for example, normal hybridization methods or the PCR technique from
other eukaryotes such as those identified above for example. These DNA sequences hybridize under standard conditions
with the said sequences. For hybridization use is advantageously made of short oligonucleotides of the conserved
regions, for example, which can be determined by comparisons with other desaturase genes in the manner known to
those skilled in the art. The histidine box sequences are advantageously employed. However, longer fragments of the
nucleic acids according to the invention or the complete sequences may also be used for hybridization. Depending on
the nucleic acid employed: oligonucleotide, longer fragment or complete sequence, or depending on which type of nucleic
acid, DNA or RNA, is used for hybridization these standard conditions vary. Thus, for example, the melting temperatures
of DNA:DNA hybrids are approximately 10 °C lower than those of DNA:RNA hybrids of the same length.
[0015] By standard conditions is meant, for example, depending on the nucleic acid in question temperatures between
42 °C and 58 °C in an aqueous buffer solution having a concentration of between 0.1 and 5 x SSC (1 X SSC = 0.15 M
NaCl, 15 mM sodium citrate, pH 7.2) or additionally in the presence of 50 % formamide, such as by way of example 42
°C in 5 x SSC, 50 % formamide. Hybridization conditions for DNA: DNA hybrids are advantageously 0.1 x SSC and
temperatures between approximately 20 °C and 45 °C, preferably between approximately 30 °C and 45 °C. For DNA:
RNA hybrids the hybridization conditions are advantageously 0.1 x SSC and temperatures between approximately 30
°C and 55 °C, preferably between approximately 45 °C and 55 °C. These specified temperatures for hybridization are
melting temperature values calculated by way of example for a nucleic acid having a length of approximately 100
nucleotides and a G + C content of 50 % in the absence of formamide. The experimental conditions for DNA hybridization
are described in relevant genetics textbooks such as by way of example Sambrook et al., "Molecular Cloning", Cold
Spring Harbor Laboratory, 1989, and may be calculated by formulae known to those skilled in the art, for example as a
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function of the length of the nucleic acids, the nature of the hybrids or the G + C content. Those skilled in the art may
draw on the following textbooks for further information on hybridization: Ausubel et al. (eds), 1985, Current Protocols in
Molecular Biology, John Wiley & Sons, New York; Hames and Higgins (eds), 1985, Nucleic Acids Hybridization: A
Practical Approach, IRL Press at Oxford University Press, Oxford; Brown (ed), 1991, Essential Molecular Biology: A
Practical Approach, IRL Press at Oxford University Press, Oxford.
[0016] Furthermore, by derivatives is meant homologues of the sequences SEQ ID NO: 1 and NO: 3, for example
eukaryotic homologues, truncated sequences, single-stranded DNA of the encoding and nonencoding DNA sequence
or RNA of the encoding and nonencoding DNA sequence.
[0017] In addition, by homologues of the sequences SEQ ID NO: 1 and SEQ ID NO: 3 is meant derivatives such as
by way of example promoter variants. These variants may be modified by one or more nucleotide exchanges, by insertion
(s) and/or deletion(s) without, however, adversely affecting the functionality or efficiency of the promoters. Furthermore,
the promoters can have their efficiency increased by altering their sequence or be completely replaced by more effective
promoters even of foreign organisms.
[0018] By derivatives is also advantageously meant variants whose nucleotide sequence has been altered in the
region from -1 to -2000 ahead of the start codon in such a way that the gene expression and/or the protein expression
is modified, preferably increased. Furthermore, by derivatives is also meant variants which have been modified at the
3’ end.
[0019] By derivatives is also meant the antisense DNAs which may be employed for inhibiting protein biosynthesis of
the proteins according to the invention. These antisense DNAs are numbered among the nonfunctional derivatives
according to the invention such as derivatives which exhibit no enzymatic activity. Other methods known to those skilled
in the art for the production of nonfunctional derivatives are what is known as cosuppression, the use of ribozymes and
introns and the RNAi method. Ribozymes are catalytic RNA molecules having ribonuclease activity which can chop
single- stranded nucleic acids, such as mRNA, with which they are complementary. In this way, using these ribozymes
(Haselhoff and Gerlach, Nature, 334, 1988: 585-591) mRNA transcripts can be catalytically cleaved and, thus, the
translation of this mRNA is suppressed. Ribozymes of this type can be specially tailored to their purpose (US 4,987,071;
US 5,116,742 and Bartel et al., Science 261, 1993: 1411-1418). By this means, with the aid of the antisense DNA, fatty
acids, lipids or oils having an increased content of saturated fatty acids can be produced.
[0020] The nucleic acid sequence according to the invention which encodes a ∆ 6-desaturase may be produced by
synthesis or obtained naturally or contain a mixture of synthetic and natural DNA components as well as consist of
various heterologous ∆ 6-desaturase gene segments from different organisms. In general, synthetic nucleotide sequenc-
es are produced with codons which are preferred by the corresponding host organisms, plants for example. This usually
results in optimum expression of the heterologous gene. These codons preferred by plants may be determined from
codons having the highest protein frequency which are expressed in most of the plant species of interest. An example
concerning Corynebacterium glutamicum is provided in Wada et al. (1992) Nucleic Acids Res. 20:2111-2118). Such
experiments can be carried out using standard methods and are known to the person skilled in the art.
[0021] Functionally equivalent sequences which encode the ∆ 6-desaturase gene are those derivatives of the sequence
according to the invention which despite differing nucleotide sequence still possess the desired functions, that is to say
the enzymatic activity and specific selectivity of the proteins. Thus, functional equivalents include naturally occurring
variants of the sequences described herein as well as artificial ones, e.g. artificial nucleotide sequences adapted to the
codon use of a plant which have been obtained by chemical synthesis.
[0022] In addition, artificial DNA sequences are suitable, provided, as described above, they mediate the desired
property, for example an increase in the content of ∆6 double bonds in fatty acids, oils or lipids in organisms such as in
a plant by overexpression of the ∆6-desaturase gene in crop plants. Such artificial DNA sequences can exhibit ∆6-
desaturase activity, for example by back-translation of proteins constructed by means of molecular modeling, or be
determined by in vitro selection. Possible techniques for in vitro evolution of DNA to modify or improve the DNA sequences
are described in Patten, P.A. et al., Current Opinion in Biotechnology 8, 724-733(1997) or in Moore, J.C. et al., Journal
of Molecular Biology 272, 336-347 (1997). Particularly suitable are encoding DNA sequences which are obtained by
back-translation of a polypeptide sequence in accordance with the codon use specific to the host plant. Those skilled
in the art familiar with the methods of plant genetics can easily determine the specific codon use by computer analyses
of other known genes of the plant to be transformed.
[0023] Other suitable equivalent nucleic acid sequences which may be mentioned are sequences that encode fusion
proteins, a component of the fusion protein being a ∆6-desaturase polypeptide or a functionally equivalent part thereof.
The second part of the fusion protein can be, for example, another polypeptide having enzymatic activity or an antigenic
polypeptide sequence by means of which it is possible to demonstrate ∆6-desaturase expression (e.g. myc tag or his
tag). Preferably, however, this is a regulatory protein sequence, such as by way of example a signal sequence for the
endoplasmic reticulum (= ER) which directs the ∆ 6-desaturase protein to the desired point of action, or regulatory
sequences which influence the expression of the nucleic acid sequence according to the invention, such as promoters
or terminators.
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[0024] Advantageously, the ∆6-desaturase genes in the method according to the invention may be combined with
other genes for fatty acid biosynthesis. Examples of such genes are the acetyl transferases, other desaturases or
elongases such as ∆ 4-, ∆ 5-, ∆ 6- or ∆ 8- desaturases or ω-3- and/or ω-6-specific desaturases such as ∆ 12 (for C18
fatty acids), ∆ 15 (for C18 fatty acids) or ∆ 19 (for C22 fatty acids) or such as ∆ 5- or ∆ 6-elongases. For in vivo and
especially in vitro synthesis combination with e.g. NADH cytochrome B5 reductases which can take up or release
reduction equivalents is advantageous.
[0025] By the amino acid sequences according to the invention is meant proteins which contain an amino acid sequence
depicted in the sequences SEQ ID NO: 2 and SEQ ID NO: 4 or a sequence obtainable therefrom by substitution, inversion,
insertion or deletion of one or more amino acid groups, the enzymatic activities of the proteins depicted in SEQ ID NO:
2 and NO: 4 being retained or not substantially reduced, that is they still possess the same enzymatic activity. By "not
substantially reduced" or "the same enzymatic activity" is meant all enzymes which still exhibit at least 10 %, preferably
20 %, particularly preferably 30 %, of the enzymatic activity of the initial enzyme obtained from the wild form of the said
Primulaceae organism. In doing this, for example, certain amino acids may be replaced by others having similar phys-
icochemical properties (space filling, basicity, hydrophobicity, etc.). For example, arginine residues are exchanged for
lysine residues, valine residues for isoleucine residues or aspartic acid residues for glutamic acid residues. However,
one or more amino acids may also be swapped in sequence, added or removed, or a plurality of these measures may
be combined with one another.
[0026] By derivatives is also meant functional equivalents which in particular also contain natural or artificial mutations
of an originally isolated sequence encoding ∆6- desaturase which continue to exhibit the desired function, that is the
enzymatic activity and substrate selectivity thereof is not substantially reduced. Mutations comprise substitutions, addi-
tions, deletions, exchanges or insertions of one or more nucleotide residues. Thus, for example, the present invention
also encompasses those nucleotide sequences which are obtained by modification of the ∆6-desaturase nucleotide
sequence. The aim of such a modification may be, e.g., to further bound the encoding sequence contained therein or
also, e.g., to insert further restriction enzyme interfaces.
[0027] Functional equivalents also include those variants whose function by comparison with the initial gene or gene
fragment is weakened (= not substantially reduced) or reinforced (= enzyme activity higher than the activity of the initial
enzyme, that is activity is higher than 100 %, preferably higher than 110 %, particularly preferably higher than 130 %).
[0028] At the same time the nucleic acid sequence may, for example, advantageously be a DNA or cDNA sequence.
Suitable encoding sequences for insertion into an expression cassette according to the invention include by way of
example those which encode a ∆ 6- desaturase with the sequences described above and lend the host the ability to
overproduce fatty acids, oils or lipids having double bonds in the ∆6 position, it being advantageous when at the same
time ω-3 fatty acids having at least four double bonds are produced. These sequences may be of homologous or
heterologous origin.
[0029] By the expression cassette (= nucleic acid construct or fragment or gene construct) according to the invention
is meant the sequences specified in SEQ ID NO: 1 and SEQ ID NO:3 which result from the genetic code and/or functional
or nonfunctional derivatives thereof which are functionally linked with one or more regulation signals advantageously to
increase the gene expression and which control the expression of the encoding sequence in the host cell. These regulatory
sequences should allow the selective expression of the genes and the protein expression. Depending on the host
organism this may mean, for example, that the gene is expressed and/or overexpressed only after induction or that it is
expressed and/or overexpressed immediately. Examples of these regulatory sequences are sequences to which induc-
tors or repressors bind and in this way regulate the expression of the nucleic acid. In addition to these new regulation
sequences or instead of these sequences the natural regulation of these sequences ahead of the actual structural genes
may still be present and optionally have been genetically modified so that natural regulation was switched off and the
expression of the genes increased. However, the gene construct can also be built up more simply, that is no additional
regulation signals have been inserted ahead of the nucleic acid sequence or derivatives thereof and the natural promoter
with its regulation has not been removed. Instead of this the natural regulation sequence was mutated in such a way
that no further regulation ensues and/or the gene expression is heightened. These modified promoters in the form of
part sequences (= promoter containing parts of the nucleic acid sequences according to the invention) can also be
brought on their own ahead of the natural gene to increase the activity. In addition, the gene construct may advantageously
also contain one or more so- called enhancer sequences functionally linked to the promoter which allow enhanced
expression of the nucleic acid sequence. At the 3’ end of the DNA sequences additional advantageous sequences may
also be inserted, such as further regulatory elements or terminators. The ∆6-desaturase gene may be present in one or
more copies in the expression cassette (= gene construct).
[0030] As described above, the regulatory sequences or factors can preferably positively influence and so increase
the gene expression of the introduced genes. Thus, reinforcement of the regulatory elements advantageously on the
transcription level may be effected by using powerful transcription signals such as promoters and/or enhancers. However,
in addition reinforcement of translation is also possible, for example by improving the stability of the mRNA.
[0031] Suitable promoters in the expression cassette are in principle all promoters which can control the expression
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of foreign genes in organisms such as microorganisms like protozoa such as ciliates, algae such as green, brown, red
or blue algae, bacteria such as gram- positive or gram- negative bacteria, yeasts such as Saccharomyces, Pichia or
Schizosaccharomyces or fungi such as Mortierella, Traustochytrium or Schizochytrium, advantageously in plants or
fungi. Use is preferably made in particular of plant promoters or promoters derived from a plant virus. Advantageous
regulation sequences for the method according to the invention are found for example in promoters such as cos, tac,
trp, tet, trp- tet, lpp, lac, lpp-lac, lacIq-, T7, T5, T3, gal, trc, ara, SP6, λ-PR or in λ-PL promoters which are employed
advantageously in gram-negative bacteria. Other advantageous regulation sequences are found, for example, in the
gram-positive promoters amy and SPO2, in the yeast or fungal promoters ADC1, MFα, AC, P-60, CYC1, GAPDH, TEF,
rp28, ADH or in the plant promoters CaMV/35S [Franck et al., Cell 21(1980) 285-294], SSU, OCS, lib4, STLS1, B33,
nos (= Nopalin Synthase Promoter) or in the ubiquintin promoter. The expression cassette may also contain a chemically
inducible promoter by means of which the expression of the exogenous ∆ 6- desaturase gene in the organisms can be
controlled advantageously in the plants at a particular time. Advantageous plant promoters of this type are by way of
example the PRP1 promoter [Ward et al., Plant.Mol. Biol.22(1993), 361-366], a promoter inducible by benzenesulfon-
amide (EP 388186), a promoter inducible by tetracycline (Gatz et al., (1992) Plant J. 2,397-404), a promoter inducible
by salicylic acid (WO 95/19443), a promoter inducible by abscisic acid (EP335528) and a promoter inducible by ethanol
or cyclohexanone (WO93/21334). Other examples of plant promoters which can advantageously be used are the pro-
moter of cytosolic FBPase from potato, the ST-LSI promoter from potato (Stockhaus et al., EMBO J. 8 (1989) 2445-245),
the promoter of phosphoribosyl pyrophosphate amidotransferase from Glycine max (see also gene bank accession
number U87999) or a nodiene- specific promoter as described in EP 249676. Particularly advantageous are those plant
promoters which ensure expression in tissues or plant parts/organs in which fatty acid biosynthesis or the precursor
stages thereof occurs, as in endosperm or in the developing embryo for example. Particularly noteworthy are advanta-
geous promoters which ensure seed-specific expression such as by way of example the USP promoter or derivatives
thereof, the LEB4 promoter, the phaseolin promoter or the napin promoter. The particularly advantageous USP promoter
cited according to the invention or its derivatives mediate very early gene expression in seed development (Baeumlein
et al., Mol Gen Genet, 1991, 225 (3): 459-67). Other advantageous seed- specific promoters which may be used for
monocotylodonous or dicotylodonous plants are the promoters suitable for dicotylodons such as napin gene promoters,
likewise cited by way of example, from oilseed rape (US 5,608,152), the oleosin promoter from Arabidopsis (WO
98/45461), the phaseolin promoter from Phaseolus vulgaris (US 5,504,200), the Bce4 promoter from Brassica (WO
91/13980) or the leguminous B4 promoter (LeB4, Baeumlein et al., Plant J., 2, 2, 1992: 233 - 239) or promoters suitable
for monocotylodons such as the promoters of the lpt2 or lpt1 gene in barley (WO 95/15389 and WO 95/23230) or the
promoters of the barley hordeine gene, the rice glutelin gene, the rice oryzin gene, the rice prolamin gene, the wheat
gliadin gene, the white glutelin gene, the corn zein gene, the oats glutelin gene, the sorghum kasirin gene or the rye
secalin gene which are described in WO99/16890.
[0032] Furthermore, particularly preferred are those promoters which ensure the expression in tissues or plant parts
in which, for example, the biosynthesis of fatty acids, oils and lipids or the precursor stages thereof takes place. Particularly
noteworthy are promoters which ensure a seed-specific expression. Noteworthy are the promoter of the napin gene
from oilseed rape (US 5,608,152), the USP promoter from Vicia faba (USP = unknown seed protein, Baeumlein et al.,
Mol Gen Genet, 1991, 225 (3): 459-67), the promoter of the oleosin gene from Arabidopsis (WO98/45461), the phaseolin
promoter (US 5,504,200) or the promoter of the legumin B4 gene (LeB4; Baeumlein et al., 1992, Plant Journal, 2 (2):
233-9). Other promoters to be mentioned are that of the lpt2 or 1pt1 gene from barley (WO95/15389 and WO95/23230)
which mediate seed- specific expression in monocotyledonous plants.
[0033] As described above, the expression construct (= gene construct, nucleic acid construct) may contain yet other
genes which are to be introduced into the organisms. These genes can be subject to separate regulation or be subject
to the same regulation region as the ∆ 6-desaturase gene. These genes are by way of example other biosynthesis
genes, advantageously for fatty acid biosynthesis, which allow increased synthesis. Examples which may be mentioned
are the genes for ∆ 15-, ∆ 12-, ∆ 9-, ∆ 6-, ∆ 5-, ∆ 4-desaturase, β-ketoacyl reductases, β-ketoacyl synthases, elongases
or the various hydroxylases and acyl- ACP thioesterases. The desaturase genes are advantageously used in the nucleic
acid construct.
[0034] In principle all natural promoters with their regulation sequences can be used like those named above for the
expression cassette according to the invention and the method according to the invention. Over and above this, synthetic
promoters may also advantageously be used.
[0035] In the preparation of an expression cassette various DNA fragments can be manipulated in order to obtain a
nucleotide sequence which usefully reads in the correct direction and is equipped with a correct reading raster. To
connect the DNA fragments (= nucleic acids according to the invention) to one another adaptors or linkers may be
attached to the fragments.
[0036] The promoter and the terminator regions can usefully be provided in the transcription direction with a linker or
polylinker containing one or more restriction points for the insertion of this sequence. Generally, the linker has 1 to 10,
mostly 1 to 8, preferably 2 to 6, restriction points. In general the size of the linker inside the regulatory region is less than
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100 bp, frequently less than 60 bp, but at least 5 bp. The promoter may be both native or homologous as well as foreign
or heterologous to the host organism, for example to the host plant. In the 5’-3’ transcription direction the expression
cassette contains the promoter, a DNA sequence which encodes a ∆6-desaturase gene and a region for transcription
termination. Different termination regions can be exchanged for one another in any desired fashion.
[0037] Furthermore, manipulations which provide suitable restriction interfaces or which remove excess DNA or re-
striction interfaces can be employed. Where insertions, deletions or substitutions, such as transitions and transversions,
come into consideration, in vitro mutagenesis, primer repair, restriction or ligation may be used. In suitable manipulations
such as restriction, chewing back or filling of overhangs for blunt ends complementary ends of the fragments can be
provided for the ligation.
[0038] For an advantageous high expression the attachment of the specific ER retention signal SEKDEL inter alia can
be of importance (Schouten, A. et al., Plant Mol. Biol. 30 (1996), 781-792). In this way the average expression level is
tripled or even quadrupled. Other retention signals which occur naturally in plant and animal proteins located in the ER
may also be employed for the construction of the cassette.
[0039] Preferred polyadenylation signals are plant polyadenylation signals, preferably those which substantially cor-
respond to T- DNA polyadenylation signals from Agrobacterium tumefaciens, in particular gene 3 of the T-DNA (octopin
synthase) of the Ti plasmid pTiACH5 (Gielen et al., EMBO J.3 (1984), 835 et seq.) or corresponding functional equivalents.
[0040] An expression cassette is produced by fusion of a suitable promoter with a suitable ∆6-desaturase DNA se-
quence together with a polyadenylation signal by common recombination and cloning techniques as described, for
example, in T. Maniatis, E.F. Fritsch and J. Sambrook, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor
Laboratory, Cold Spring Harbor, NY (1989) as well as in T.J. Silhavy, M.L. Berman and L.W. Enquist, Experiments with
Gene Fusions, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1984) and in Ausubel, F.M. et al., Current
Protocols in Molecular Biology, Greene Publishing Assoc. and Wiley- Interscience (1987).
[0041] In the preparation of an expression cassette various DNA fragments can be manipulated to produce a nucleotide
sequence which usefully reads in the correct direction and is equipped with a correct reading raster. Adapters or linkers
can be attached to the fragments for joining the DNA fragments.
[0042] The promoter and the terminator regions can usefully be provided in the transcription direction with a linker or
polylinker containing one or more restriction points for the insertion of this sequence. Generally, the linker has 1 to 10,
mostly 1 to 8, preferably 2 to 6, restriction points. In general the size of the linker inside the regulatory region is less than
100 bp, frequently less than 60 bp, but at least 5 bp. The promoter may be both native or homologous as well as foreign
or heterologous to the host organism, for example to the host plant. In the 5’-3’ transcription direction the expression
cassette contains the promoter, a DNA sequence which encodes a ∆6-desaturase gene and a region for transcription
termination. Different termination regions can be exchanged for one another in any desired fashion.
[0043] In the preparation of an expression cassette various DNA fragments can be manipulated to produce a nucleotide
sequence which usefully reads in the correct direction and is equipped with a correct reading raster. Adapters or linkers
can be attached to the fragments for joining the DNA fragments.
[0044] The DNA sequences encoding two ∆6-desaturases from Muscariodides vialii and Aleuritia farinosa contain all
the sequence characteristics needed to achieve correct localization of the site of fatty acid, lipid or oil biosynthesis.
Accordingly, no further targeting sequences are needed per se. However, such a localization may be desirable and
advantageous and hence artificially modified or reinforced so that such fusion constructs are also a preferred advanta-
geous embodiment of the invention.
[0045] Particularly preferred are sequences which ensure targeting in plastids. Under certain circumstances targeting
into other compartments (reported in: Kermode, Crit. Rev. Plant Sci. 15, 4 (1996), 285-423) may also be desirable, e.g.
into vacuoles, the mitochondrium, the endoplasmic reticulum (ER), peroxisomes, lipid structures or due to lack of cor-
responding operative sequences retention in the compartment of origin, the cytosol.
[0046] Advantageously, the nucleic acid sequences according to the invention or the gene construct together with at
least one reporter gene are cloned into an expression cassette which is introduced into the organism via a vector or
directly into the genome. This reporter gene should allow easy detection via a growth, fluorescence, chemical, biolumi-
nescence or resistance assay or via a photometric measurement. Examples of reporter genes which may be mentioned
are antibiotic- or herbicide-resistance genes, hydrolase genes, fluorescence protein genes, bioluminescence genes,
sugar or nucleotide metabolic genes or biosynthesis genes such as the Ura3 gene, the Ilv2 gene, the luciferase gene,
the β-galactosidase gene, the gfp gene, the 2-desoxyglucose- 6-phosphate phosphatase gene, the β-glucuronidase
gene, β-lactamase gene, the neomycin phosphotransferase gene, the hygromycin phosphotransferase gene or the
BASTA (= gluphosinate-resistance) gene. These genes permit easy measurement and quantification of the transcription
activity and hence of the expression of the genes. In this way genome positions may be identified which exhibit differing
productivity.
[0047] In a preferred embodiment an expression cassette comprises upstream, i.e. at the 5’ end of the encoding
sequence, a promoter and downstream, i.e. at the 3’ end, a polyadenylation signal and optionally other regulatory
elements which are operably linked to the intervening encoding sequence for ∆ 6- desaturase and/or ∆ 6-desaturase
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DNA sequence. By an operable linkage is meant the sequential arrangement of promoter, encoding sequence, terminator
and optionally other regulatory elements in such a way that each of the regulatory elements can fulfill its function in the
expression of the encoding sequence in due manner. The sequences preferred for operable linkage are targeting se-
quences for ensuring subcellular localization in plastids. However, targeting sequences for ensuring subcellular locali-
zation in the mitochondrium, in the endoplasmic reticulum (= ER), in the nucleus, in oil corpuscles or other compartments
may also be employed as well as translation promoters such as the 5’ lead sequence in tobacco mosaic virus (Gallie et
al., Nucl. Acids Res. 15 (1987), 8693 -8711).
[0048] An expression cassette may, for example, contain a constitutive promoter or a tissue- specific promoter (pref-
erably the USP or napin promoter) the gene to be expressed and the ER retention signal. For the ER retention signal
the KDEL amino acid sequence (lysine, aspartic acid, glutamic acid, leucine) or the KKX amino acid sequence (lysine-
lysine-X-stop, wherein X means every other known amino acid) is preferably employed.
[0049] For expression in a prokaryotic or eukaryotic host organism, for example a microorganism such as a fungus
or a plant the expression cassette is advantageously inserted into a vector such as by way of example a plasmid, a
phage or other DNA which allows optimum expression of the genes in the host organism. Examples of suitable plasmids
are: in E. coli pLG338, pACYC184, pBR series such as e.g. pBR322, pUC series such as pUC18 or pUC19, M113mp
series, pKC30, pRep4, pHS1, pHS2, pPLc236, pMBL24, pLG200, pUR290, pIN-III113-B1, λgt11 or pBdCI; in Strepto-
myces pIJ101, pIJ364, pIJ702 or pIJ361; in Bacillus pUB110, pC194 or pBD214; in Corynebacterium pSA77 or pAJ667;
in fungi pALS1, pIL2 or pBB116; other advantageous fungal vectors are described by Romanos, M.A. et al., [(1992)
"Foreign gene expression in yeast: a review", Yeast 8: 423-488] and by van den Hondel, C.A.M.J.J. et al. [(1991)
"Heterologous gene expression in filamentous fungi" as well as in More Gene Manipulations in Fungi [J.W. Bennet &
L.L. Lasure, eds., pp. 396-428: Academic Press: San Diego] and in "Gene transfer systems and vector development for
filamentous fungi" [van den Hondel, C.A.M.J.J. & Punt, P.J. (1991) in: Applied Molecular Genetics of Fungi, Peberdy,
J.F. et al., eds., pp. 1-28, Cambridge University Press: Cambridge]. Examples of advantageous yeast promoters are
2∝M, pAG-1, YEp6, YEp13 or pEMB-LYe23. Examples of algal or plant promoters are pLGV23, pGHlac+, pBIN19,
pAK2004, pVKH or pDH51 (see Schmidt, R. and Willmitzer, L., 1988). The vectors identified above or derivatives of the
vectors identified above are a small selection of the possible plasmids. Further plasmids are well known to those skilled
in the art and may be found, for example, in the book Cloning Vectors (Eds. Pouwels P.H. et al. Elsevier, Amsterdam-
New York-Oxford, 1985 , ISBN 0 444 904018). Suitable plant vectors are described inter alia in "Methods in Plant
Molecular Biology and Biotechnology" (CRC Press), Ch. 6/7, pp. 71-119. Advantageous vectors are known as shuttle
vectors or binary vectors which replicate in E. coli and Agrobacterium.
[0050] By vectors is meant with the exception of plasmids all other vectors known to those skilled in the art such as
by way of example phages, viruses such as SV40, CMV, baculovirus, adenovirus, transposons, IS elements, phasmids,
phagemids, cosmids, linear or circular DNA. These vectors can be replicated autonomously in the host organism or be
chromosomally replicated, chromosomal replication being preferred.
[0051] In a further embodiment of the vector the expression cassette according to the invention may also advanta-
geously be introduced into the organisms in the form of a linear DNA and be integrated into the genome of the host
organism by way of heterologous or homologous recombination. This linear DNA may be composed of a linearized
plasmid or only of the expression cassette as vector or the nucleic acid sequences according to the invention.
[0052] In a further advantageous embodiment the nucleic acid sequence according to the invention can also be
introduced into an organism on its own.
[0053] If in addition to the nucleic acid sequence according to the invention further genes are to be introduced into
the organism, all together with a reporter gene in a single vector or each single gene with a reporter gene in a vector in
each case can be introduced into the organism, whereby the different vectors can be introduced simultaneously or
successively.
[0054] The vector advantageously contains at least one copy of the nucleic acid sequences according to the invention
and/or the expression cassette (= gene construct) according to the invention.
[0055] By way of example the plant expression cassette can be installed in the pRT transformation vector ((a) Toepfer
et al., 1993, Methods Enzymol., 217: 66-78; (b) Toepfer et al. 1987, Nucl. Acids. Res. 15: 5890 ff.).
[0056] Alternatively, a recombinant vector (= expression vector) can also be transcribed and translated in vitro, e.g.
by using the T7 promoter and the T7 RNA polymerase.
[0057] Expression vectors employed in prokaryotes frequently make use of inducible systems with and without fusion
proteins or fusion oligopeptides, wherein these fusions can ensue in both N-terminal and C-terminal manner or in other
useful domains of a protein. Such fusion vectors usually have the following purposes: i.) to increase the RNA expression
rate; ii.) to increase the achievable protein synthesis rate; iii.) to increase the solubility of the protein; iv.) or to simplify
purification by means of a binding sequence usable for affinity chromatography. Proteolytic cleavage points are also
frequently introduced via fusion proteins which allows cleavage of a portion of the fusion protein and purification. Such
recognition sequences for proteases are recognized, e.g. factor Xa, thrombin and enterokinase.
[0058] Typical advantageous fusion and expression vectors are pGEX [Pharmacia Biotech Inc; Smith, D.B. and John-
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son, K.S. (1988) Gene 67: 31-40], pMAL (New England Biolabs, Beverly, MA) and pRIT5 (Pharmacia, Piscataway, NJ)
which contains glutathione S-transferase (GST), maltose binding protein or protein A.
[0059] Other examples of E. coli expression vectors are pTrc [Amann et al., (1988) Gene 69:301-315] and pET vectors
[Studier et al., Gene Expression Technology: Methods in Enzymology 185, Academic Press, San Diego, California
(1990) 60-89; Stratagene, Amsterdam, The Netherlands].
[0060] Other advantageous vectors for use in yeast are pYepSec1 (Baldari, et al., (1987) Embo J. 6:229-234), pMFa
(Kurjan and Herskowitz, (1982) Cell 30:933-943), pJRY88 (Schultz et al., (1987) Gene 54:113-123), and pYES derivatives
(Invitrogen Corporation, San Diego, CA). Vectors for use in filamentous fungi are described in: van den Hondel, C.A.M.J.J.
& Punt, P.J. (1991) "Gene transfer systems and vector development for filamentous fungi", in: Applied Molecular Genetics
of Fungi, J.F. Peberdy, et al., eds., pp. 1-28, Cambridge University Press: Cambridge.
[0061] Alternatively, insect cell expression vectors can also be advantageously utilized, e.g. for expression in Sf 9
cells. These are e.g. the vectors of the pAc series (Smith et al. (1983) Mol. Cell Biol. 3:2156-2165) and the pVL series
(Lucklow and Summers (1989) Virology 170: 31-39).
[0062] Furthermore, plant cells or algal cells can advantageously be used for gene expression. Examples of plant
expression vectors may be found in Becker, D., et al. (1992) "New plant binary vectors with selectable markers located
proximal to the left border", Plant Mol. Biol. 20: 1195-1197 or in Bevan, M.W. (1984) "Binary Agrobacterium vectors for
plant transformation", Nucl. Acid. Res. 12: 8711-8721.
[0063] Furthermore, the nucleic acid sequences according to the invention may be expressed in mammalian cells,
advantageously in nonhuman mammalian cells. Examples of corresponding expression vectors are pCDM8 and pMT2PC
referred to in: Seed, B. (1987) Nature 329: 840 or Kaufman et al. (1987) EMBO J. 6: 187-195). At the same time promoters
preferred for use are of viral origin, such as by way of example promoters of polyoma, adenovirus 2, cytomegalovirus
or simian virus 40. Other prokaryotic and eukaryotic expression systems are referred to in chapters 16 and 17 of Sambrook
et al., Molecular Cloning: A Laboratory Manual. 2nd, ed., Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory
Press, Cold Spring Harbor, NY, 1989.
[0064] The introduction of the nucleic acids according to the invention, the expression cassette or the vector into
organisms, plants for example, can in principle be done by all of the methods known to those skilled in the art. The
introduction of the nucleic acid sequences gives rise to recombinant or transgenic organisms.
[0065] In the case of microorganisms, those skilled in the art can find appropriate methods in the textbooks by Sam-
brook, J. et al. (1989) Molecular cloning: A laboratory manual, Cold Spring Harbor Laboratory Press, by F.M. Ausubel
et al. (1994) Current protocols in molecular biology, John Wiley and Sons, by D.M. Glover et al., DNA Cloning Vol.1,
(1995), IRL Press (ISBN 019-963476-9), by Kaiser et al. (1994) Methods in Yeast Genetics, Cold Spring Harbor Laboratory
Press or Guthrie et al. Guide to Yeast Genetics and Molecular Biology, Methods in Enzymology, 1994, Academic Press.
[0066] The transfer of foreign genes into the genome of a plant is called transformation. In doing this the methods
described for the transformation and regeneration of plants from plant tissues or plant cells are utilized for transient or
stable transformation. Suitable methods are protoplast transformation by poly(ethylene glycol)-induced DNA uptake, the
"biolistic" method using the gene cannon - referred to as the particle bombardment method, electroporation, the incubation
of dry embryos in DNA solution, microinjection and gene transfer mediated by Agrobacterium. Said methods are described
by way of example in B. Jenes et al., Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1, Engineering and
Utilization, eds. S.D. Kung and R. Wu, Academic Press (1993) 128-143 and in Potrykus Annu. Rev. Plant Physiol. Plant
Molec. Biol. 42 (1991) 205-225). The construct to be expressed is preferably cloned into a vector which is suitable for
transforming Agrobacterium tumefaciens, for example pBin19 (Bevan et al., Nucl. Acids Res. 12 (1984) 8711). Agro-
bacteria transformed by such a vector can then be used in known manner for the transformation of plants, in particular
of crop plants such as by way of example tobacco plants, for example by bathing bruised leaves or chopped leaves in
an agrobacterial solution and then culturing them in suitable media. The transformation of plants by means of Agrobac-
terium tumefaciens is described, for example, by Höfgen and Willmitzer in Nucl. Acid Res. (1988) 16, 9877 or is known
inter alia from F.F. White, Vectors for Gene Transfer in Higher Plants; in Transgenic Plants, Vol. 1, Engineering and
Utilization, eds. S.D. Kung and R. Wu, Academic Press, 1993, pp. 15-38.
[0067] Agrobacteria transformed by an expression vector according to the invention may likewise be used in known
manner for the transformation of plants such as test plants like Arabidopsis or crop plants such as cereal crops, corn,
oats, rye, barley, wheat, soybean, rice, cotton, sugar beet, canola, sunflower, flax, hemp, potatoes, tobacco, tomatoes,
carrots, paprika, oilseed rape, tapioca, cassava, arrowroot, tagetes, alfalfa, lettuce and the various tree, nut and vine
species, in particular of oil-containing crop plants such as soybean, peanut, castor oil plant, sunflower, corn, cotton, flax,
oilseed rape, coconut, oil palm, safflower (Carthamus tinctorius) or cocoa bean, e.g. by bathing bruised leaves or chopped
leaves in an agrobacterial solution and then culturing them in suitable media. For the production of PUFAs, for example
stearidonic acid, eicosapentaenoic acid and docosahexaenoic acid, borage or Primulaceae are advantageously suitable.
[0068] The genetically modified plant cells may be regenerated by all of the methods known to those skilled in the art.
Appropriate methods can be found in the publications referred to above by S.D. Kung and R. Wu, Potrykus or Höfgen
and Willmitzer.
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[0069] Accordingly, a further aspect of the invention relates to transgenic organisms transformed by at least one
nucleic acid sequence, expression cassette or vector according to the invention as well as cells, cell cultures, tissue,
parts - such as, for example, leaves, roots, etc. in the case of plant organisms - or reproductive material derived from
such organisms. The terms "host organism", "host cell", "recombinant (host) organism" and "transgenic (host) cell" are
used here interchangeably. Of course these terms relate not only to the particular host organism or the particular target
cell but also to the descendants or potential descendants of these organisms or cells. Since, due to mutation or envi-
ronmental effects certain modifications may arise in successive generations, these descendants need not necessarily
be identical with the parental cell but nevertheless are still encompassed by the term as used here.
[0070] For the purposes of the invention "transgenic" or "recombinant" means with regard for example to a nucleic
acid sequence, an expression cassette (= gene construct) or a vector containing the nucleic acid sequence according
to the invention or an organism transformed by the nucleic acid sequences, expression cassette or vector according to
the invention all those constructions produced by genetic engineering methods in which either
a) the nucleic acid sequence according to the invention or
b) a genetic control sequence functionally linked to the nucleic acid sequence according to the invention, for example
a promoter, or
c) (a) and (b)
are not found in their natural, genetic environment or have been modified by genetic engineering methods, wherein the
modification may by way of example be a substitution, addition, deletion, inversion or insertion of one or more nucleotide
residues. Natural genetic environment means the natural genomic or chromosomal locus in the organism of origin or
presence in a genomic library. In the case of a genomic library the natural genetic environment of the nucleic acid
sequence is preferably retained at least in part. The environment borders the nucleic acid sequence at least on one side
and has a sequence length of at least 50 bp, preferably at least 500 bp, particularly preferably at least 1,000 bp, most
particularly preferably at least 5,000 bp. A naturally occurring expression cassette - for example the naturally occurring
combination of the natural promoter of the nucleic acid sequence according to the invention with the corresponding PSE
gene - turns into a transgenic expression cassette when the latter is modified by unnatural, synthetic ("artificial") methods
such as by way of example a mutagenation. Appropriate methods are described by way of example in US 5,565,350 or
WO 00/15815.
[0071] Suitable organisms or host organisms for the nucleic acid, expression cassette or vector according to the
invention are advantageously in principle all organisms which are able to synthesize fatty acids, especially unsaturated
fatty acids or are suitable for the expression of recombinant genes. Examples which may be mentioned are plants such
as Arabidopsis, Asteraceae such as Calendula or crop plants such as soybean, peanut, castor oil plant, sunflower, corn,
cotton, flax, oilseed rape, coconut, oil palm, safflower (Carthamus tinctorius) or cocoa bean, microorganisms such as
fungi, for example the genus Mortierella, Saprolegnia or Pythium, bacteria such as the genus Escherichia, yeasts such
as the genus Saccharomyces, cyanobacteria, ciliates, algae or protozoa such as dinoflagellates like Crypthecodinium.
Preference is given to organisms which can naturally synthesize oils in relatively large quantities such as fungi like
Mortierella alpina, Pythium insidiosum or plants such as soybean, oilseed rape, coconut, oil palm, safflower, flax, castor
oil plant, Calendula, peanut, cocoa bean or sunflower, or yeasts such as Saccharomyces cerevisiae and particular
preference is given to soybean, flax, oilseed rape, sunflower, Calendula, Mortierella or Saccharomyces cerevisiae. In
principle, apart from the transgenic organisms identified above, transgenic nonhuman animals are suitable, for example
C. elegans.
[0072] Further useful host cells are identified in: Goeddel, Gene Expression Technology: Methods in Enzymology
185, Academic Press, San Diego, CA (1990).
[0073] Usable expression strains, e.g. those exhibiting a relatively low protease activity, are described in: Gottesman,
S., Gene Expression Technology: Methods in Enzymology 185, Academic Press, San Diego, California (1990) 119-128.
[0074] A further object of the invention relates to the use of an expression cassette containing DNA sequences encoding
a ∆6-desaturase gene or DNA sequences hybridizing therewith for the transformation of plant cells, tissues or parts of
plants. The aim of use is to increase the content of fatty acids, oils or lipids having an increased content of double bonds
in the ∆6 position.
[0075] In doing so, depending on the choice of promoter, the ∆6-desaturase gene can be expressed specifically in
the leaves, in the seeds, the nodules, in roots, in the stem or other parts of the plant. Those transgenic plants overproducing
fatty acids, oils or lipids having ∆6 double bonds, the reproductive material thereof, together with the plant cells, tissues
or parts thereof are a further object of the present invention. A preferred object according to the invention comprises
transgenic plants containing a functional or nonfunctional (= antisense DNA or enzymatically inactive enzyme) nucleic
acid sequence or a functional or nonfunctional expression cassette according to the invention.
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[0076] The expression cassette or the nucleic acid sequences according to the invention containing a ∆6- desaturase
gene sequence can, moreover, also be employed for the transformation of the organisms identified by way of example
above such as bacteria, cyanobacteria, yeasts, filamentous fungi, ciliates and algae with the objective of increasing the
content of fatty acids, oils or lipids possessing ∆6 double bonds.
[0077] Within the framework of the present invention, increasing the content of fatty acids, oils or lipids possessing ∆
6 double bonds means, for example, the artificially acquired trait of increased biosynthetic performance due to functional
overexpression of the ∆6-desaturase gene in the organisms according to the invention, advantageously in the transgenic
plants according to the invention, by comparison with the nongenetically modified initial plants at least for the duration
of at least one plant generation.
[0078] The preferred locus of biosynthesis, of fatty acids, oils or lipids for example, is generally the seed or cell layers
of the seed so that a seed-specific expression of the ∆6-desaturase gene is appropriate. It is, however, obvious that the
biosynthesis of fatty acids, oils or lipids need not be limited to the seed tissue but rather can also occur in tissue- specific
manner in all other parts of the plant - in epidermis cells or in the nodules for example.
[0079] A constitutive expression of the exogenous ∆6- desaturase gene is, moreover, advantageous. On the other
hand, however, an inducible expression may also appear desirable.
[0080] The efficiency of the expression of the ∆ 6-desaturase gene can be determined, for example, in vitro by shoot
meristem propagation. In addition, an expression of the ∆6-desaturase gene modified in nature and level and its effect
on fatty acid, oil or lipid biosynthesis performance can be tested on test plants in greenhouse trials.
[0081] An additional object of the invention comprises transgenic organisms such as transgenic plants transformed
by an expression cassette containing a ∆6- desaturase gene sequence according to the invention or DNA sequences
hybridizing therewith, as well as transgenic cells, tissue, parts and reproduction material of such plants. Particular
preference is given in this case to transgenic crop plants such as by way of example barley, wheat, rye, oats, corn,
soybean, rice, cotton, sugar beet, oilseed rape and canola, sunflower, flax, hemp, thistle, potatoes, tobacco, tomatoes,
oilseed rape, tapioca, cassava, arrowroot, alfalfa, lettuce and the various tree, nut and vine species.
[0082] For the purposes of the invention plants are mono- and dikotylodonous plants, mosses or algae.
[0083] A further refinement according to the invention are transgenic plants as described above which contain a
functional or nonfunctional nucleic acid sequence according to the invention or a functional or nonfunctional expression
cassette according to the invention. By nonfunctional is meant that an enzymatically active protein is no longer synthe-
sized. Moreover, by nonfunctional nucleic acids or nucleic acid constructs is also means what is known as an antisense
DNA which results in transgenic plants which show a reduction in enzymatic activity or no enzymatic activity. With the
aid of the antisense technique, especially when the nucleic acid sequence is combined in the antisense DNA with other
fatty acid synthesis genes, it is possible to synthesize triglycerides having an increased content of saturated fatty acids
or saturated fatty acids. Furthermore, by means of what is known as coexpression or by means of the RNAi technique
transgenic plants can be manipulated in such a way that no or reduced enzymatic activity is produced in the plants. By
transgenic plants is meant single plant cells and cultures thereof on fixed media or in liquid culture, parts of plants and
entire plants.
[0084] Other objects of the invention are: 
- A method for the transformation of a plant comprising the introduction of expression cassettes according to the
invention containing a ∆6- desaturase gene sequence derived from Primulaceae or DNA’ sequences hybridizing
therewith into a plant cell, into callus tissue, an entire plant or protoplasts of plants.
- A method for producing PUFAs, wherein the method comprises the growing of a transgenic organism comprising
a nucleic acid as claimed in claims 1 to 4, a gene construct as claimed in claim 6 or a vector as claimed in claim 7
encoding a ∆ 6- desaturase which specifically desaturates ω-3 fatty acids, and wherein due to the activity of the ∆
6-desaturase PUFAs are formed in the organism which exhibit an increased content of ω-3 fatty acids. In this method
ω-3 fatty acids such as stearidonic acid, eicosapentaenoic acid or docosahexaenoic acid are advantageously pro-
duced.
- Use of a ∆6-desaturase DNA gene sequence or DNA sequences hybridizing therewith for the production of plants
having an increased content of fatty acids, oils or lipids having ∆6 double bonds due to the expression of said ∆6-
desaturase DNA sequence in plants.
- Use of a ∆6- desaturase DNA gene sequence DNA sequences hybridizing therewith for the production of plants
having an increased content of fatty acids, oils or lipids having ∆6 double bonds, particularly of ω-3 fatty acids, due
to the expression of said ∆6- desaturase DNA sequence in plants.
- Proteins containing the amino acid sequences depicted in SEQ ID NO: 2 or NO: 4.
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- Use of said proteins having the sequences SEQ ID NO: 2 or NO: 4 for producing unsaturated fatty acids.
[0085] A further object according to the invention is a method for producing unsaturated fatty acids comprising: intro-
ducing at least one said nucleic acid sequence according to the invention or at least one nucleic acid construct according
to the invention into a preferably oil-producing plant; growing said organism; isolating oil contained in said organism;
and liberating the fatty acids present in said oil. These unsaturated fatty acids advantageously contain ∆6 double bonds.
The fatty acids may be liberated from the oils or lipids, for example by basic hydrolysis, e.g. using NaOH or KOH.
[0086] A method for producing triglycerides having an increased content of unsaturated fatty acids comprising: intro-
ducing at least one said nucleic acid sequence according to the invention or at least one expression cassette according
to the invention into an oil- producing organism; growing said organism; and isolating oil contained in said organism; is
also numbered among the objects of the invention.
[0087] A further object according to the invention is a method for producing triglycerides having an increased content
of unsaturated fatty acids by incubating triglycerides containing saturated or unsaturated or saturated and unsaturated
fatty acids with at least one of the proteins encoded by the sequences SEQ ID NO: 2 or NO: 4. The method is advan-
tageously carried out in the presence of compounds which can take up or release reduction equivalents. The fatty acids
can then be liberated from the triglycerides.
[0088] A further object according to the invention of said method for producing triglycerides having an increased
content of saturated or unsaturated fatty acids or saturated and unsaturated fatty acids advantageously having an
increased content of unsaturated fatty acids is a method wherein the fatty acids are liberated from the triglycerides with
the aid of basic hydrolysis known to those skilled in the art or by means of an enzyme such as a lipase.
[0089] The methods specified above advantageously allow the synthesis of fatty acids or triglycerides having an
increased content of fatty acids containing ∆6 double bonds.
[0090] The methods identified above advantageously allow the synthesis of fatty acids or triglycerides having an
increased content of fatty acids containing ∆6 double bonds, wherein the substrate used for the reaction of the ∆ 6-
desaturase is preferably α-linolenic acid. In this way the method identified above advantageously allows in particular
the synthesis of fatty acids derived from stearidonic acid (C18:4∆6, 9, 12, 15) such as by way of example eicosapentaenoic
acid and docosahexaenoic acid.
[0091] Using what is known as antisense technology, in one method fatty acids or triglycerides having an increased
content of saturated fatty acids can also be produced.
[0092] Examples of organisms for the said methods which may be mentioned are plants such as Arabidopsis, Primu-
laceae, borage, barley, wheat, rye, oats, corn, soybean, rise, cotton, sugar beet, oilseed rape and canola, sunflower,
flax, hemp, potatoes, tobacco, tomatoes, rape, tapioca, cassava, arrowroot, alfalfa, peanut, castor oil plant, coconut, oil
palm, safflower (Carthamus tinctorius) or cocoa bean, microorganisms such as the fungi Mortierella, Saprolegnia or
Pythium, bacteria such as the genus Escherichia, cyanobacteria, yeasts such as the genus Saccharomyces, algae or
protozoa such as dinoflagellates like Crypthecodinium. Preference is given to organisms which can naturally synthesize
oils in relatively large quantities such as fungi like Mortierella alpina, Pythium insidiosum or plants such as soybean,
oilseed rape, coconut, oil palm, safflower, castor oil plant, Calendula, peanut, cocoa bean or sunflower, or yeasts such
as Saccharomyces cerevisiae and particular preference is given to soybean, oilseed rape, sunflower, flax, Primulaceae,
borage, Carthamus or Saccharomyces cerevisiae.
[0093] Depending on the host organism, the organisms used in the methods are grown or cultured in the manner
known to those skilled in the art. Microorganisms are usually grown in a liquid medium containing a carbon source,
usually in the form of sugars, a nitrogen source, usually in the form of organic nitrogen sources such as yeast extract
or salts such as ammonium sulfate, trace elements such as iron, manganese or magnesium salts and optionally vitamins
at temperatures of between 10 °C and 60 °C with exposure to gaseous oxygen. In doing so the pH of the nutrient liquid
may be kept at a fixed value, that is during growth it is or is not regulated. Growth can ensue in batch mode, semibatch
mode or continuously. Nutrients can be provided at the start of fermentation or be fed in semicontinuously or continuously.
[0094] After transformation plants are first of all regenerated as described above and then cultured or cultivated as
normal.
[0095] After growth the lipids are isolated from the organisms in the usual way. For this purpose, after harvesting the
organisms may first of all be digested or used directly. The lipids are advantageously extracted using suitable solvents
such as apolar solvents like hexane or ethanol, isopropanol or mixtures such as hexane/isopropanol, phenol/chloroform/
isoamyl alcohol at temperatures of between 0 °C and 80 °C, preferably between 20 °C and 50°C. The biomass is usually
extracted with an excess of solvent, for example an excess of solvent to biomass of 1: 4. The solvent is then removed,
for example by distillation. Extraction can also be done using supercritical CO2. After extraction the remaining biomass
may be removed, for example by filtration.
[0096] The crude oil isolated in this way can then be further purified, for example by removing cloudiness by treatment
with polar solvents such as acetone or chloroform and then filtration or centrifugation. Further purification through columns
is also possible.
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[0097] In order to obtain the free acids from the triglycerides the latter are saponified in the usual way.
[0098] Also disclosed are unsaturated fatty acids and triglycerides having an increased content of unsaturated fatty
acids produced by the methods identified above and use thereof for producing foods, animal feeds, cosmetics or phar-
maceuticals. For this purpose the latter are added in customary quantities to the foods, the animal feed, the cosmetics
or pharmaceuticals.
[0099] Said unsaturated fatty acids disclosed herein as well as triglycerides having an increased content of unsaturated
fatty acids produced by the methods identified above are the result of the expression of the nucleic acids according to
the invention in the various host organisms. This results overall in a modification of the composition of the compounds
in the host cell containing unsaturated fatty acids by comparison with the original starting host cells which do not contain
the nucleic acids. These modifications are more marked in host organisms, for example plant cells, which naturally do
not contain the proteins or enzymes encoded by the nucleic acids than in host organisms which naturally do contain the
proteins or enzymes encoded by the nucleic acids. This gives rise to host organisms containing oils, lipids, phospholipids,
sphingolipids, glycolipids, triacylglycerols and/or free fatty acids having a higher content of PUFAs. For the purposes of
the invention, by an increased content is meant that the host organisms contain at least 5 %, advantageously at least
10 %, preferably at least 20 %, particularly preferably at least 30 %, most particularly preferably at least 40 % more
polyunsaturated fatty acids by comparison with the initial organism which does not contain the nucleic acids according
to the invention. This is particularly the case for plants which do not naturally contain longer-chain polyunsaturated C20
or C22 fatty acids such as DHA, EPA or ARA. Due to the expression of the nucleic acids novel lipid compositions are
produced by said means these being a further aspect of the invention.
[0100] The invention is explained in more detail by the following examples.
Examples
Example 1: General cloning methods
[0101] The cloning methods, such as by way of example restriction cleavages, agarose gel electrophoresis, purification
of DNA fragments, transfer of nucleic acids to nitrocellulose and nylon membranes, linkage of DNA fragments, trans-
formation of Escherichia coli cells, culture of bacteria and sequence analysis of recombinant DNA, were carried out as
described in Sambrook et al. (1989) (Cold Spring Harbor Laboratory Press: ISBN 0-87969-309-6).
Example 2: Sequence analysis of recombinant DNA
[0102] Sequencing of recombinant DNA molecules was done using a laser fluorescence DNA sequencer from the
ABI company by the method of Sanger (Sanger et al. (1977) Proc. Natl. Acad. Sci. USA74, 5463-5467). Fragments
resulting from a polymerase chain reaction were sequenced and checked to prevent polymerase errors in the constructs
to be expressed.
Example 3: Cloning of the ∆ 6-desaturase from Muscariodides vialii (= SEQ ID NO: 3)
[0103] Total RNA from young Muscariodides vialii leaves was isolated with the aid of the RNAeasy kit from the Qiagen
company (Valencia, CA, USA). With the aid of oligo-dT-cellulose poly- A+RNA (mRNA) was isolated from the total RNA
(Sambrook et al., 1989). Using the Reverse Transcription System kit from Promega the RNA was reverse transcribed
and the synthesized cDNA was used for PCR amplification of the ∆ 6- desaturases. Degenerate primers were used for
the amplification of the ∆ 6- desaturase. The nucleotide sequence was derived from the first and the third histidine box
motif of borage A 6-desaturase (Syanova et al., 1997, WO9621022).
Primer 1: GGITGGHTIGGICAYGAYKYIKSICA
Primer 2: GGRAAIAGRTGRTGYTCDATYTG
[0104] In the primers identified here and in the primer sequences set out below the symbols or letters in accordance
with Wobble IUPAC-IUB have the following meaning:
R = A/G; Y = C/T; M = A/ C ; K = G/ T ; S = G/C; W = A/T; H = A/ C/T; B = G/T/C; V = G/C/A; D = G/T/A und N = G/A/T/C.
PCR protocol
[0105]
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Addition temperature: 1 min at 45 °C
Denaturing temperature: 1 min at 94 °C
Elongation temperature: 2 min at 72 °C
Number of cycles: 35
[0106] The PCR mixture was separated on an agarose gel and a 660 bp fragment was isolated. The PCR fragment
was cloned in the pGEM- T easy vector (Promega) and the insert was then sequenced.
[0107] The missing 5’ and 3’ region of the isolated gene fragment from Muscariodides vialii was isolated with the aid
of the Smart RACE cDNA kit (Clonetech) and then sequenced. Starting from 3’ and 5’ sequence primers were derived
in order to isolate the complete clone. For this purpose primers were derived from the DNA regions around the start
methionine and the stop codon. The PCR yielded a single band of the expected size. The cDNA was again cloned in
the pGEM T easy vector and the now complete gene was sequenced.
Example 4: Cloning of the ∆ 6-desaturase from Aleuritia farinosa (= SEQ ID NO: 1)
[0108] Total RNA from young Aleuritia farinose leaves was isolated with the aid of the RNAeasy kit from the Qiagen
company (Valencia, CA, USA). With the aid of oligo-dT-cellulose poly- A+ RNA (mRNA) was isolated from the total RNA
(Sambrook et al., 1989). Using the Reverse Transcription System kit from Promega the RNA was reverse transcribed
and the synthesized cDNA was used for PCR amplification of the ∆ 6- desaturases. Degenerate primers were used for
the amplification of the ∆ 6- desaturase. The nucleotide sequence was derived from the first and the third histidine box
motif of borage ∆ 6- desaturase (Syanova et al., 1997, WO9621022).
Primer 1: GGITGGHTIGGICAYGAYKYIKSICA
Primer 2: GGRAAIAGRTGRTGYTCDATYTG
PCR protocol
[0109]
Addition temperature: 1 min at 45 °C
Denaturing temperature: 1 min at 94 °C
Elongation temperature: 2 min at 72 °C
Number of cycles: 35
[0110] The PCR mixture was separated on an agarose gel and a 660 bp fragment was isolated. The PCR fragment
was cloned in the pGEM- T easy vector (Promega) and the insert was then sequenced.
[0111] The missing 5’ and 3’ region of the isolated gene fragment from Aleuritia farinose was isolated with the aid of
the Smart RACE cDNA kit (Clonetech) and then sequenced. Starting from 3’ and 5’ sequence primers were derived in
order to isolate the complete clone. For this purpose primers were derived from the DNA regions around the start
methionine and the stop codon. The PCR yielded a single band of the expected size. The cDNA was again cloned in
the pGEM T easy vector and the now complete gene was sequenced.
Example 5: Cloning of expression plasmids for constitutive expression in plants
[0112] By means of appropriate primers at the 5’ and 3’ end of both new desaturases a CLAI and a XbaI interface
was introduced.
[0113] Primer design for the ∆ 6-desaturase from M. vialii: 
atcgatatggctaacaaatctcccacc (ClaI)
tctagattagccgtgtgtgtggacggctt (XbaI)
[0114] Primer design for the ∆ 6-desaturase from A. farinosa:
atcgatatggctaacaaatctcccacc (ClaI)
tctagatcacccgagagttttaagagct (XbaI)
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[0115] The PCR products were separated in agarose gel, digested with ClaI/XbaI and ligated into the appropriately
cut vector pSLJ4K1. The resultant plasmids contain 35S promoter (cauliflower mosaic virus; Franck et al. (1980) Cell
21, 285), the A6-desaturase from Muscariodides vialii or Aleuritia farinosa and the 35S terminator in the vector pSLJ4K1.
Apart from said promoters or terminators all constitutive promoters or all plant virus promoters such as advantageously
the nos promoter (Wilkinson et al., Journal of Experimental Botany, 48, 1997: 307 et seq.) or the ubiquintin promoter
may be used. The promoters and terminators identified in the description may also advantageously be used in principle
for expression.
[0116] The constructs were used for the transformation of Arabidopsis thaliana, oilseed rape, tobacco and linseed.
Example 5: Cloning of expression plasmids for seed-specific expression in plants
[0117] For the transformation of plants a further transformation vector based on pBin-USP containing the BamHI
fragments of the ∆ 6- desaturases from M. vialii or A. farinosa was produced. The BamHI interfaces were, as described
in Example 4 [5? This is the second Example 5!], attached to the start ATGs or stop codons with the aid of appropriate
primers by PCR.
[0118] Primer design for the ∆ 6-desaturase from M. vialii: 
ggatccatggctaacaaatctcccacc
ggatccttagccgtgtgtgtggacggctt
[0119] Primer design for the ∆ 6-desaturase from A. farinosa:
ggatccatggctaacaaatctcccacc
ggatcctcacccgagagttttaagagct
[0120] pBin-USP is a derivative of the plasmid pBin19. pBin- USP was produced from pBin19 by inserting a USP
promoter as an EcoRI-BaMHI fragment into pBin19 (Bevan et al. (1980) Nucl. Acids Res. 12, 8711). The polyadenylation
signal is that of gene 3 of the T-DNA of the Ti plasmid pTiACH5 (Gielen et al., (1984) EMBO J. 3, 835), whereby
nucleotides 11749-11939 were isolated as a PvuII-HindIII fragment and after addition of SphI linkers to the PvuII interface
between the SpHI-HindIII interface of the vector were cloned. The USP promoter corresponds to nucleotides 1-684
(gene bank accession number X56240), wherein a part of the nonencoding region of the USP gene is contained in the
promoter. The promoter fragment running to 684 base pairs was amplified by standard methods by means of commercial
T7 standard primer (Stratagene) and using a synthesized primer through a PCR reaction. (Primer sequence: 5’-
GTCGACCCGCGGACTAGTGGGCCCTCTAGACCCGGGGGATCC GGATCTGC- TGGCTATGAA- 3’). The PCR frag-
ment was recut using EcoRI/ SalI and inserted into the vector pBin19 with OCS terminator. The plasmid having the
designation pBinUSP was obtained. The constructs were used for transforming Arabidopsis thaliana, oilseed rape,
tobacco and linseed.
Example 6: Production of transgenic plants
a) Production of transgenic plants (modified in accordance with Moloney et al., 1992, Plant Cell Reports, 8:238-242)
[0121] To produce transgenic oilseed rape plants binary vectors in Agrobacterium tumefaciens C58C1:pGV2260 or
Escherichia coli were used (Deblaere et al, 1984, Nucl. Acids. Res. 13, 4777-4788). For transforming oilseed rape plants
(var. Drakkar, NPZ Nordeutsche Pflanzenzucht, Hohenlieth, Germany) a 1:50 dilution of an overnight culture of a positively
transformed agrobacteria colony in Murashige-Skoog medium (Murashige and Skoog 1962 Physiol. Plant. 15, 473)
containing 3 % of saccharose (3MS medium) was used. Petioles or hypocotyledons of freshly germinated sterile rape
plants (approx. 1 cm2 each) were incubated in a Petri dish with a 1: 50 agrobacteria dilution for 5-10 minutes. This was
followed by 3-day concubation in darkness at 25 °C on 3MS medium containing 0.8 % of Bacto-Agar. After three days,
culturing was continued with 16 hours of light / 8 hours of darkness and in a weekly cycle on MS medium containing
500 mg/l of Claforan (sodium cefotaxime), 50 mg/l of kanamycin, 20 microM of benzylaminopurine (BAP) and 1.6 g/l of
glucose. Growing shoots were transferred onto MS medium containing 2 % of saccharose, 250 mg/l of Claforan and 0.8
% of Bacto- Agar. If after three weeks no roots had formed 2-indolylbutyric acid was added to the medium as a growth
hormone for rooting purposes.
[0122] Regenerated shoots were obtained on 2MS medium using kanamycin and Claforan, transferred into soil after
rooting and after culturing grown for two weeks in a climate- controlled chamber, brought to blossom and after harvesting
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of ripe seed investigated for ∆ 6- desaturase expression by means of lipid analyses. Lines having increased contents of
double bonds at the ∆ 6 position were identified. In the stably transformed transgenic lines functionally expressing the
transgene it was found that there is an increased content of double bonds at the ∆ 6 position by comparison with
untransformed control plants.
b) Transgenic flax plants may be produced, for example by the by the method Bell et al., 1999, In Vitro Cell. Dev. 
Biol.-Plant. 35(6):456-465, by means of particle bombardment. Agrobacteria-mediated transformations can be produced, 
for example, as described by Mlynarova et al. (1994), Plant Cell Report 13: 282-285.
Example 7: Lipid extraction from seed
[0123] Plant material was first of all mechanically homogenized by means of triturators in order to render it more
amenable to extraction.
[0124] It was then heated to 100 °C for 10 min and after cooling on ice sedimented again. The cell sediment was
hydrolyzed with 1 M methanolic sulfuric acid and 2 % dimethoxypropane for 1h at 90 °C and the lipids were transmeth-
ylated. The resultant fatty acid methyl esters (FAMEs) were finally extracted into petroleum ether. The extracted FAMEs
were analyzed by gas-liquid chromatograph using a capillary column (Chrompack, WCOT fused silica, CP wax 52 CB,
25 m, 0.32 mm) and a temperature gradient of from 170 °C to 240 °C in 20 min and 5 min at 240 °C. The identity of the
fatty acid methyl esters was confirmed by comparison with corresponding FAME standards (Sigma). The identity and
the position of the double bond was further analyzed by means of GC-MS by suitable chemical derivatization of the
FAME mixtures, e.g. to form 4,4-dimethoxyoxazoline derivatives (Christie, 1998). The GC analyses of the fatty acid
methyl esters obtained from the transgenic rape seeds exhibiting seed-specific expression of the ∆ 6-desaturase are
presented in Table 1. The transgenic rape seeds contained up to 5 % of γ-linolenic acid in the seed.
Example 8: Expression of ∆ 6-desaturases from Primulaceae in yeast (Saccharomyces cerevisiae)
[0125] The open reading rasters of the ∆ 6- desaturases obtained from Muscariodides vialii and Aleuritia farinosa were
each cloned behind the galactose- inducible GAL1 promoter of the yeast expression vector pYES2 (Invitrogen). The
open reading rasters were amplified by means of PCR. The interfaces used for cloning were KpnI and EcoRI.
[0126] Primer design for M. vialii:
ggtaccatggctaacaaatctcccacc (KpnI)
gaattcttagccgtgtgtgtggacggctt (EcoRI)
[0127] Primer design for A. farinosa:
ggtaccatggctaacaaatctcccacc (KpnI)
gaattctcacccgagagttttaagagct (EcoRI)
[0128] The vectors produced were used for expression in yeast. The substrate specificities were determined by feeding
the transformed yeast strains with α-linolenic acid and linoleic acid. The methodology used is described, for example,
in Napier and Michaelson, 2001,Lipids. 36(8): 761-766; Sayanova et al., 2001, Journal of Experimental Botany. 52 (360):
1581-1585, Sperling et al., 2001, Arch. Biochem. Biophys. 388 (2): 293-298 and Michaelson et al., 1998, FEBS Letters.
439(3): 215-218.
[0129] In order to compare the specificities the ∆ 6-desaturase from borage (Borago officinalis) was likewise expressed
in yeast (Sayanova et al.,1999, Plant Physiol. 121 (2): 641-646).
Table 1: Expression in yeast. Comparison of substrate specificities of ∆ 6-sesaturases from borage, A. farinosa and 
M. vialii.
Construct pYES2 Borage A. farinosa M. vialii
Fatty Acid
C16:0 24.8 20 23.2 20.3
C16:1∆9 22.5 20 18.2 21.7
C18:0 6.1 6.2 5.9 4.7
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[0130] It may be gathered from the tables that the nucleic acid sequences according to the invention encode ∆ 6-
desaturases which are specific for ω-3 fatty acids.
SEQUENZPROTOKOLL
[0131]
<110> BASF Plant Science GmbH
<120> Delta-6-desaturases from Primulaceae, expressing plants and PUFA- containing oils
<130> 2002_54
<140> 2002_54
<141> 2002-02-15
<160> 4
<170> PatentIn Vers. 2.0
<210> 1
<211> 1362
<212> DNA
<213> Aleuritia farinosa
(continued)
Construct pYES2 Borage A. farinosa M. vialii
Fatty Acid
C18:1∆9 17.1 17.1 14.9 15.8
C18:2∆,9,12 13.8 11.5 12.8 15.3
C18:3∆6,9,12 0 5.5 5 1.4
C18:3∆9,12,15 15.6 15.5 12.2 13.9
C18:4∆6,9,12,15 0 3.9 7.7 6.8
Table 2: Conversion of linoleic acid by ∆ 6- desaturase from borage and the ∆ 6- desaturases from Primulaceae by 
comparison with the conversion of α-linolenic acid.
Construct pYES2 Borage A. farinosa M. vialii
% by wt. of ∆ 6- 
desaturated 
fatty acids in 
the total fatty 
acids
nd 11.10% 14.10% 8.80%
% conversion 
of LA to A 6 fatty 
acids
nd 32.30% 28.10% 8.40%
% conversion 
of ALA to ∆ 6 
fatty acids
nd 20.10% 38.70% 32.80%
Ratio n3: n6 0.71 1.54 4.8
LA = linoleic acid (= C18:2∆9,12) ⇒∆ 6-desaturation produces C18:3∆6,9,12
ALA = α -linolenic acid (= C18:3∆9,12,15) ⇒∆ 6-desaturation produces C18:4∆6,9,12,15
nd = not determined
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<220>
<221> CDS
<222> (1)..(1362)
<400> 1
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<210> 2
<211> 453
<212> PRT
<213> Aleuritia farinosa
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<400> 2
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<210> 3
<211> 1362
<212> DNA
<213> Muscarioides vialii
<220>
<221> CDS
<222> (1)..(1362)
<400> 3
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<210> 4
<211> 453
<212> PRT
<213> Muscarioides vialii
<400> 4
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Claims
1. isolated nucleic acid sequences, which encode polypeptides having ∆-6-desaturase activity, wherein the ∆-6-de-
saturases encoded by the nucleic acid sequences specifically convert ω-3 fatty acids, selected from the group:
a) a nucleic acid sequence having the sequence depicted in SEQ ID NO: 1 or SEQ ID NO: 3,
b) nucleic acid sequences which may be derived as a result of the degenerate genetic code from the encoding
sequence contained in SEQ ID NO: 1 or SEQ ID NO: 3,
c) derivatives of the nucleic acid sequence depicted in SEQ ID NO: 1 or SEQ ID NO: 3 which encode polypeptides
using the amino acid sequences depicted in SEQ ID NO: 2 or SEQ ID NO: 4 and have at least 75 % homology
on the amino acid level with SEQ ID NO: 2 or SEQ ID NO: 4 and possess ∆-6-desaturase activity.
2. The isolated nucleic acid sequence as claimed in claim 1, wherein said sequence originates from a plant.
3. The isolated nucleic acid sequence as claimed in claims 1 or 2, wherein said sequence derives from the genera
Muscariodides or Aleuritia.
4. An amino acid sequence, which is encoded by an isolated nucleic acid sequence as claimed in any of claims 1 to 3.
5. A gene construct containing an isolated nucleic acid as claimed in any of claims 1 to 3, wherein said nucleic acid is
functionally linked to one or more regulation signals.
6. A vector containing a nucleic acid as claimed in claims 1 to 3 or a gene construct as claimed in claim 5.
7. A transgenic nonhuman organism transformed with at least one nucleic acid as claimed in claims 1 to 3, a gene
construct as claimed in claim 5 or a vector as claimed in claim 6 encoding a polypeptide having ∆-6-desaturase activity.
8. The transgenic nonhuman organism as claimed in claim 7, wherein said organism is a microorganism, a nonhuman
animal or a plant.
9. The transgenic nonhuman organism as claimed in claim 7 or 8, wherein said organism is a plant.
10. A method for producing PUFAs, wherein the method comprises growing a transgenic organism which comprises a
nucleic acid as claimed in claims 1 to 3, a gene construct as claimed in claim 5 or a vector as claimed in claim 6
encoding a ∆-6-desaturase which specifically desaturates ω-3 fatty acids, and wherein due to the activity of said ∆-
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6 desaturase PUFAs are formed in said organism which exhibit an increased content of ω-3 fatty acids.
11. The method as claimed in claim 10, wherein in the method stearidonic acid, eicosapentaenoic acid or docosahex-
aenoic acid are produced.
12. The method as claimed in claim 10 or 11, wherein the polyunsaturated fatty acid molecules are isolated from said
organism in the form of an oil, lipid or a free fatty acid.
13. The method as claimed in any of claims 10 to 12, wherein said organism is a microorganism, a nonhuman animal
or a plant.
14. The method as claimed in any of claims 10 to 13, wherein said organism is a transgenic plant.
15. The method as claimed in any of claims 10 to 14, wherein said polyunsaturated fatty acid is a C18 fatty acid having
at least three double bonds in the molecule.
16. The method as claimed in any of claims 10 to 15, wherein the produced oil, lipids or fatty acids are added in customary
quantities to foods, animal feed, cosmetics or pharmaceuticals.
Patentansprüche
1. Isolierte Nukleinsäuresequenzen, die für Polypeptide mit ∆-6-Desaturaseaktivität codieren, wobei die von den Nu-
kleinsäuresequenzen codierten ∆-6- Desaturasen spezifisch ω-3-Fettsäuren, ausgewählt aus der Gruppe:
a) eine Nukleinsäuresequenz mit der in SEQ ID NO: 1 oder SEQ ID NO: 3 dargestellten Sequenz,
b) Nukleinsäuresequenzen, die als Ergebnis des degenerierten genetischen Codes von der in SEQ ID NO: 1
oder SEQ ID NO: 3 enthaltenen codierenden Sequenz abgeleitet werden können,
c) Derivate der in SEQ ID NO: 1 oder SEQ ID NO: 3 dargestellten Nukleinsäuresequenzen, die für die in SEQ
ID NO: 2 oder SEQ ID NO: 4 dargestellten Aminosäuresequenzen verwendende Polypeptide codieren und
wenigstens 75% Homologie auf der Aminosäureebene mit SEQ ID NO: 2 oder SEQ ID NO: 4 aufweisen und
∆-6-Desaturaseaktivität besitzen,
umwandeln.
2. Isolierte Nukleinsäuresequenz nach Anspruch 1, wobei die Sequenz aus einer Pflanze stammt.
3. Isolierte Nukleinsäuresequenz nach Anspruch 1 oder 2, wobei die Sequenz aus den Gattungen Muscariodides oder
Aleuritia stammt.
4. Aminosäuresequenz, die von einer isolierten Nukleinsäuresequenz nach einem der Ansprüche 1 bis 3 codiert wird.
5. Genkonstrukt, enthaltend eine isolierte Nukleinsäure nach einem der Ansprüche 1 bis 3, wobei die Nukleinsäure
funktionell mit einem oder mehreren Regulationssignalen verknüpft ist.
6. Vektor, enthaltend eine Nukleinsäure nach Ansprüchen 1 bis 3 oder ein Genkonstrukt nach Anspruch 5.
7. Transgener nichtmenschlicher Organismus, transformiert mit wenigstens einer Nukleinsäure nach Ansprüchen 1
bis 3, einem Genkonstrukt nach Anspruch 5 oder einem Vektor nach Anspruch 6, codierend für ein Polypeptid mit
∆-6-Desaturaseaktivität.
8. Transgener nichtmenschlicher Organismus nach Anspruch 7, wobei es sich um einen Mikroorganismus, ein nicht-
menschliches Tier oder eine Pflanze handelt.
9. Transgener nichtmenschlicher Organismus nach Anspruch 7 oder 8, wobei es sich um eine Pflanze handelt.
10. Verfahren zur Herstellung von PUFAs, bei dem man einen eine Nukleinsäuresequenz nach Ansprüchen 1 bis 3,
ein Genkonstrukt nach Anspruch 5 oder ein Vektor nach Anspruch 6, codierend für eine ω-3-Fettsäuren spezifisch
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desaturierende ∆-6- Desaturase umfassenden transgenen Organismus anzieht und bei dem aufgrund der Aktivität
der ∆-6-Desaturase in dem Organismus PUFAs gebildet werden, die einen erhöhten Gehalt an ω-3-Fettsäuren
zeigen.
11. Verfahren nach Anspruch 10, wobei in dem Verfahren Stearidonsäure, Eicosapentaensäure oder Docosahexaen-
säure produziert werden.
12. Verfahren nach Anspruch 10 oder 11, wobei die mehrfach ungesättigten Fettsäuremoleküle aus dem Organismus
in Form eines Öls, eines Lipids oder einer freien Fettsäure isoliert werden.
13. Verfahren nach einem der Ansprüche 10 bis 12, wobei es sich bei dem Organismus um einen Mikroorganismus,
ein nichtmenschliches Tier oder eine Pflanze handelt.
14. Verfahren nach einem der Ansprüche 10 bis 13, wobei es sich bei dem Organismus um eine transgene Pflanze
handelt.
15. Verfahren nach einem der Ansprüche 10 bis 14, wobei es sich bei der mehrfach ungesättigten Fettsäure um eine
C18-Fettsäure mit wenigstens drei Doppelbindungen im Molekül handelt.
16. Verfahren nach einem der Ansprüche 10 bis 15, wobei das produzierte Öl, die produzierten Lipide oder Fettsäuren
in herkömmlichen Mengen Lebensmitteln, Tierfutter, Kosmetika oder Pharmazeutika zugesetzt werden.
Revendications
1. Séquences d’acides nucléiques isolées, qui codent pour des polypeptides ayant une activité de ∆-6-désaturase,
les ∆-6- désaturases codées par les séquences d’acides nucléiques convertissant de manière spécifique des acides
gras ω-3, ces séquences étant choisies parmi le groupe :
a) une séquence d’acide nucléique présentant la séquence représentée dans SEQ ID NO : 1 ou SEQ ID NO : 3,
b) des séquences d’acides nucléiques qui peuvent être dérivées, comme un résultat du code génétique dégé-
néré, de la séquence codante contenue dans SEQ ID NO : 1 ou SEQ ID NO : 3,
c) des dérivés de la séquence d’acide nucléique représentée dans SEQ ID NO : 1 ou SEQ ID NO : 3 qui codent
pour des polypeptides utilisant les séquences d’acides aminés représentées dans SEQ ID NO : 2 ou SEQ ID
NO : 4 et ont au moins 75 % d’homologie au niveau acides aminés avec SEQ ID NO : 2 ou SEQ ID NO : 4 et
possèdent une activité de ∆-6- désaturase.
2. Séquence d’acides nucléiques isolée suivant la revendication 1, dans laquelle ladite séquence est originaire d’une
plante.
3. Séquence d’acides nucléiques isolée suivant les revendications 1 ou 2, dans laquelle ladite séquence dérive du
genre Muscariodides ou Aleuritia.
4. Séquence d’acides aminés qui est codée par une séquence d’acides nucléiques isolée suivant l’une quelconque
des revendications 1 à 3.
5. Construction génique contenant un acide nucléique isolé suivant l’une quelconque des revendications 1 à 3, dans
laquelle ledit acide nucléique est fonctionnellement lié à un ou plusieurs signaux de régulation.
6. Vecteur contenant un acide nucléique suivant les revendications 1 à 3 ou une construction génique suivant la
revendication 5.
7. Organisme non humain transgénique transformé par au moins un acide nucléique suivant les revendications 1 à 3,
une construction génique suivant la revendication 5 ou un vecteur suivant la revendication 6 codant pour un poly-
peptide ayant une activité de ∆-6- désaturase.
8. Organisme non humain transgénique suivant la revendication 7, dans lequel ledit organisme est un micro- organisme,
un animal non humain ou une plante.
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9. Organisme non humain transgénique suivant la revendication 7 ou 8, dans lequel ledit organisme est une plante.
10. Procédé de production d’acides gras polyinsaturés, comprenant le développement d’un organisme transgénique
qui comprend un acide nucléique suivant les revendications 1 à 3, une construction génique suivant la revendication
5 ou un vecteur suivant la revendication 6 codant pour une ∆-6-désaturase qui désature spécifiquement des acides
gras ω-3, et dans lequel, à la suite de l’activité de ladite ∆-6-désaturase, des acides gras polyinsaturés sont formés
dans ledit organisme qui montre une teneur accrue en acides gras ω-3.
11. Procédé suivant la revendication 10, dans lequel de l’acide stéaridonique, de l’acide éicosapentaénoïque ou de
l’acide docosahexaénoïque sont produits.
12. Procédé suivant la revendication 10 ou 11, dans lequel les molécules d’acide gras polyinsaturé sont isolées dudit
organisme sous la forme d’une huile, d’un lipide ou d’un acide gras libre.
13. Procédé suivant l’une quelconque des revendications 10 à 12, dans lequel ledit organisme est un micro-organisme,
un animal non humain ou une plante.
14. Procédé suivant l’une quelconque des revendications 10 à 13, dans lequel ledit organisme est une plante transgé-
nique.
15. Procédé suivant l’une quelconque des revendications 10 à 14, dans lequel ledit acide gras polyinsaturé est un acide
gras en C18 qui présente au moins trois doubles liaisons dans la molécule.
16. Procédé suivant l’une quelconque des revendications 10 à 15, dans lequel l’huile, les lipides ou les acides gras
produits sont ajoutés en des quantités habituelles à des aliments, de la nourriture pour animaux, des produits
cosmétiques ou pharmaceutiques.
